NASDAQ:CCXI - ChemoCentryx Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$10.96 +0.10 (+0.92 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$10.96
Today's Range$10.72 - $10.96
52-Week Range$8.77 - $15.08
Volume165,554 shs
Average Volume368,120 shs
Market Capitalization$553.76 million
P/E Ratio30.44
Dividend YieldN/A

Analyst Ratings

ChemoCentryx (NASDAQ:CCXI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for ChemoCentryx in the last 12 months. Their average twelve-month price target is $17.5833, suggesting that the stock has a possible upside of 60.43%. The high price target for CCXI is $20.00 and the low price target for CCXI is $12.50. There are currently 3 hold ratings, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.672.672.80
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $17.5833$17.10$17.10$17.75
Price Target Upside: 60.43% upside42.98% upside70.15% upside40.09% upside

ChemoCentryx (NASDAQ:CCXI) Consensus Price Target History

Price Target History for ChemoCentryx (NASDAQ:CCXI)

ChemoCentryx (NASDAQ:CCXI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/14/2019Svb LeerinkReiterated RatingOutperformN/AView Rating Details
2/11/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$20.00HighView Rating Details
1/8/2019B. RileyInitiated CoverageNeutral$12.50LowView Rating Details
11/12/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.00HighView Rating Details
8/14/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$14.00 ➝ $15.00HighView Rating Details
8/13/2018HC WainwrightReiterated RatingBuy$20.00HighView Rating Details
6/28/2018Raymond JamesInitiated CoverageStrong-Buy$18.00HighView Rating Details
5/10/2018CowenReiterated RatingHoldMediumView Rating Details
2/21/2017JMP SecuritiesInitiated CoverageMkt Outperform ➝ OutperformN/AView Rating Details
(Data available from 2/16/2017 forward)
This page was last updated on 2/16/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel